Will Yuhan and Gilead cooperate for the hepatitis C drug, ‘Sovaldi’?

The alliance of Gilead and Yuhan Corporation, which has shown the perfect match in the hepatitis B market, has attracted attention for possibility to keep the trend in the hepatitis C treatment market.

So far, at least, it has displayed a positive circumstance. According to the industry concerned on the 15^th, the two companies are adjusting opinions for a domestic sales contract of ‘Sovaldi(so...